| Financial Year |
March 31 2023 |
| Monetary Funds |
215,162,414.82 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
306,874.70 |
| Accounts Receivable |
594,907,094.38 |
| Advances to Suppliers |
197,032,579.54 |
| Other Receivables |
8,191,171.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
696,171,675.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,603,773.56 |
| Total Current Assets |
2,004,019,918.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
375,128,900.22 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
86,757,213.07 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
197,072.83 |
| Deferred Income Tax Assets |
26,655,375.39 |
| Other Non-Current Assets |
2,188,655.79 |
| Sub-Total of Non-Current Assets |
491,940,095.98 |
| Total Assets |
2,495,960,014.47 |
| Short-Term Loans |
360,362,177.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
396,053,062.69 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,938,518.46 |
| Taxes Payable |
8,801,108.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,960,795.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
800,345.72 |
| Other Current Liabilities |
99,649,732.06 |
| Sub-Total of Current Liabilities |
1,645,102,141.24 |
| Long-term Loans |
140,134,247.31 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
168,575.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
159,159,837.75 |
| Total Liabilities |
1,804,261,978.99 |
| Paid-In Capital(Or Share Stock) |
202,000,000.00 |
| Capital Surplus |
224,216,664.96 |
| Surplus Reserve |
53,260,937.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
211,746,437.13 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
691,698,035.48 |
| Owner's Equity（Stockholder's Equity） |
691,698,035.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,495,960,014.47 |
